["{\n\"step_by_step_thinking\": \"Based on the provided documents, specifically 'New antipsychotics: classification, efficacy, and adverse effects' and 'Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons', remoxipride is a specific D2 dopamine antagonist. As such, it does not block 5HT receptors.\",\n\"answer_choice\": \"A\"\n}"]